MARKETS

BSE Prices delayed by 5 minutes... Prices as on Feb 22, 2019 - 10:37AM   ABB India 1257.85 [ 0.65% ]ACC 1383.4 [ -0.48% ]Ambuja Cements Ltd. 210.45 [ 0.21% ]Asian Paints Ltd. 1391.4 [ -0.45% ]Axis Bank Ltd. 695.6 [ -0.19% ]Bajaj Auto Ltd. 2844.6 [ 1.24% ]Bank of Baroda 102.55 [ -0.44% ]Bharti Airtel 312.05 [ 0.60% ]Bharat Heavy Ele 63.3 [ 0.72% ]Bharat Petroleum 342.35 [ 2.19% ]Britannia Ind. 3028.35 [ 0.80% ]Cairn India Ltd. 285.4 [ 0.90% ]Cipla 541.1 [ -0.37% ]Coal India 214.9 [ 0.56% ]Colgate Palm. 1252.6 [ 1.07% ]Dabur India 431.2 [ 1.07% ]DLF Ltd. 167.5 [ 1.09% ]Dr. Reddy's Labs 2618.2 [ 1.26% ]GAIL (India) Ltd. 330.1 [ -0.50% ]Grasim Inds. 753.75 [ 0.96% ]HCL Technologies 1067.45 [ 1.32% ]HDFC 1886 [ -0.30% ]HDFC Bank 2111.5 [ -0.17% ]Hero MotoCorp 2689 [ 1.71% ]Hindustan Unilever L 1767.5 [ 0.79% ]Hindalco Indus. 193.4 [ -0.46% ]ICICI Bank 353.05 [ 0.76% ]IDFC L 36.5 [ 0.97% ]Indian Hotels Co 142.5 [ -0.42% ]IndusInd Bank 1479.05 [ 0.51% ]Infosys 733.3 [ -0.01% ]ITC Ltd. 273.8 [ -0.40% ]Jindal St & Pwr 154.3 [ -0.68% ]Kotak Mahindra Bank 1243.9 [ -3.49% ]L&T 1278.95 [ -0.26% ]Lupin Ltd. 772 [ 0.25% ]Mahi. & Mahi 643 [ 1.52% ]Maruti Suzuki India 6915.4 [ 1.74% ]MTNL 13.57 [ -2.30% ]Nestle India 10665 [ 0.64% ]NIIT Ltd. 82.55 [ -0.18% ]NMDC Ltd. 95.75 [ 0.47% ]NTPC 137.05 [ 0.33% ]ONGC 149 [ 1.36% ]Punj. NationlBak 73.2 [ 0.00% ]Power Grid Corpo 182.05 [ 0.17% ]Reliance Inds. 1238.65 [ -0.63% ]SBI 268.75 [ 0.45% ]Vedanta 167.5 [ 1.76% ]Shipping Corpn. 36.1 [ 1.98% ]Sun Pharma. 432.15 [ 0.56% ]Tata Chemicals 564.8 [ -0.33% ]Tata Global Beverage 188.65 [ -0.68% ]Tata Motors Ltd. 171.1 [ 0.82% ]Tata Steel 496.85 [ -0.21% ]Tata Power Co. 67.55 [ 0.22% ]Tata Consultancy 1920.25 [ 0.42% ]Tech Mahindra Ltd. 822.85 [ 0.30% ]UltraTech Cement 3660.55 [ 0.81% ]United Spirits 535.4 [ -0.05% ]Wipro Ltd 379 [ 1.20% ]Zee Entertainment En 445.4 [ -0.26% ]

News Details

You can view in detail.
Glenmark Pharmaceuticals gets ANDA nod for Sevelamer Hydrochloride tablets 11/02/2019 11:59

Drug maker Glenmark Pharmaceuticals Inc., USA (Glenmark) on Monday said that, “it has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a generic version of Renagel®1 Tablets, 400 mg and 800 mg, of Genzyme Corporation,” in a filing to Bombay Stock Exchange.

According to IQVIATM sales data for the 12 month period ending December 2018, the Renagel® Tablets, 400 mg and 800 mg market2 achieved annual sales of approximately $102.1 million.

“Glenmark’s current portfolio consists of 149 products authorized for distribution in the U.S. marketplace and 53 ANDA’s pending approval with the U.S. FDA,” the company said.

In addition to these internal filings, Glenmark continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio.

The shares of the company were trading at 605.00 apiece, low at 9.45 points or 1.54 per cent at 11:55 hours on the BSE.

LOAD MORE